Neurocrine Biosciences, Inc.

NBIX · Healthcare · $14.3B

After-hours $140.86+0.11%

Price

$174.3

$138.3

Jul 2, 26Sep 29, 26

What's this stock's score right now?

See its score for free — revenue and money flow, graded on one standard.

Quarterly Financials

RevenueOperating IncomeNet Income

9/'26

Revenue$1.0B+8.8%

6/'26 vs prev quarter

Company Health

Market Cap$14.3B

Operating Margin+23.3%

Cash on Hand$390M2.7% of market cap

Free Cash Flow$870M6.1% of market cap

Short Float 5.2% · biweekly · settled 26.05.15

Among 327 Biotechnology peers

LowMedianHigh

PSR4.2xmedian 11.7xPER20.2xmedian 14.9xPBR3.6xmedian 2.1xROE+17.7%median -54.5%